Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
PUT
Oneok
OKE
$59.4B
| $10.6M | 0.01% |
206,800
+73,500
| +55% | +$3.48M |
|
1477
PUT
First Majestic Silver
AG
$10.4B
| $10.6M | 0.01% |
1,030,500
+777,000
| +307% | +$11.4M |
|
1478
Chubb
CB
$133B
| $10.6M | 0.01% |
84,403
-11,638
| -12% | -$1.48M |
|
1479
PUT
Sony
SONY
$142B
| $10.6M | 0.01% |
1,596,000
+1,490,500
| +1,413% | +$9.55M |
|
1480
PUT
Ashland
ASH
$3.39B
| $10.6M | 0.01% |
186,822
-26,776
| -13% | -$1.54M |
|
1481
CALL
Coeur Mining
CDE
$22.1B
| $10.6M | 0.01% |
894,700
+250,400
| +39% | +$3.43M |
|
1482
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.3B
| $10.6M | 0.01% |
265,064
-97,852
| -27% | -$3.68M |
|
1483
PUT
Thor Industries
THO
$4.07B
| $10.6M | 0.01% |
124,600
+76,100
| +157% | +$5.91M |
|
1484
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$255M
| $10.6M | 0.01% |
431,075
+308,080
| +250% | +$7.79M |
|
1485
PUT
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.88B
| $10.5M | 0.01% |
174,300
-151,800
| -47% | -$8.87M |
|
|
UNIT
1486
PUT
Uniti Group
UNIT
$2.47B
| $10.5M | 0.01% |
335,000
+83,900
| +33% | +$2.58M |
|
1487
PUT
ServiceNow
NOW
$130B
| $10.5M | 0.01% |
664,500
-840,500
| -56% | -$12.4M |
|
1488
PUT
Ventas
VTR
$48.1B
| $10.5M | 0.01% |
148,800
+101,400
| +214% | +$7.36M |
|
1489
PUT
Darden Restaurants
DRI
$24.9B
| $10.5M | 0.01% |
171,200
-25,900
| -13% | -$1.61M |
|
1490
CALL
iShares Russell Mid-Cap ETF
IWR
$57.6B
| $10.5M | 0.01% |
240,800
-34,400
| -13% | -$1.49M |
|
1491
PUT
Dycom Industries
DY
$9.32B
| $10.5M | 0.01% |
128,300
-25,000
| -16% | -$2.21M |
|
1492
PUT
Genuine Parts
GPC
$19.2B
| $10.5M | 0.01% |
104,100
+71,200
| +216% | +$7.22M |
|
1493
PUT
ProShares Ultra NASDAQ Biotechnology
BIB
$106M
| $10.4M | 0.01% |
215,600
+152,800
| +243% | +$7.26M |
|
1494
CALL
Lear
LEA
$8.24B
| $10.4M | 0.01% |
86,000
-12,100
| -12% | -$1.38M |
|
|
WES
1495
CALL
DELISTED
Western Gas Partners Lp
WES
| $10.4M | 0.01% |
189,200
-299,800
| -61% | -$15M |
|
1496
Johnson & Johnson
JNJ
$651B
| $10.4M | 0.01% |
88,000
-30,700
| -26% | -$3.72M |
|
1497
PUT
MPLX
MPLX
$60B
| $10.4M | 0.01% |
307,000
-3,800
| -1% | -$125K |
|
1498
PUT
Plains GP Holdings
PAGP
$5.54B
| $10.4M | 0.01% |
301,389
+160,345
| +114% | +$4.83M |
|
1499
PUT
Ally Financial
ALLY
$13B
| $10.4M | 0.01% |
533,300
-284,300
| -35% | -$5.28M |
|
1500
CALL
ProShares UltraShort S&P500
SDS
$396M
| $10.3M | 0.01% |
6,307
-8,115
| -56% | -$13.5M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.